FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.”
Elise Amendola / AP Photo
Elise Amendola / AP Photo
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.”
(Philadelphia) — A Chinese scientist accused of participating in a conspiracy to steal trade secrets from pharmaceutical giant GlaxoSmithKline is back in the United States after being extradited to stand trial in Philadelphia.
The Philadelphia Inquirer reported Tuesday that 50-year-old biochemist Gongda Xue had fought extradition from Switzerland.
He’s alleged to have received cancer research his sister stole from a research facility in the Philadelphia suburbs.
Xue appeared in federal court Monday to face charges that include conspiracy, theft of trade secrets and wire fraud.
His defense attorneys have denied the allegations.
Get insights into WITF’s newsroom and an invitation to join in the pursuit of trustworthy journalism.
